Top Markets
#1 Velas Velas +562.78%
#2 Polymath Polymath +529.94%
#3 Galxe Galxe +96.05%
#4 XION XION +63.34%
#5 Resolv wstUSR Resolv wstUSR +59.11%
#6 Nomina Nomina +45.78%
#7 Cofinex Cofinex +26.87%
#8 Swarms Swarms +16.74%
#9 Unibase Unibase +15.72%
#10 Cysic Cysic +14.51%
Coin of the day
Velas Velas
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Exscientia plc Exscientia plc

Exscientia plc

EXAI
Rang in aandelen #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Aandeelprijs
$4.84
Marktkapitalisatie
$633.18M
Verandering (1 dag)
3.20%
Verandering (1 jaar)
0.00%
Land
GB
Handel Exscientia plc (EXAI)

Categorie

Healthcare
Winst voor Exscientia plc (EXAI)
Winst in Sep 2024 TTM: $-207.65M
Volgens de meest recente financiële verslagen van Exscientia plc bedraagt de huidige winst van het bedrijf $-207.65M. In 2022 behaalde het bedrijf een winst van $-167.36M, een daling ten opzichte van de winst van 2021, die $-56.36M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Exscientia plc van 2019 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $-207.65M 0.64%
2023 $-206.34M 23.29%
2022 $-167.36M 196.95%
2021 $-56.36M 24.08%
2020 $-45.42M 224.78%
2019 $-13.99M 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
$20.46B -9,951.57%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$4.64B -2,336.03%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
$5.23B -2,618.95%
US
UCB SA UCB SA
UCB SA
UCB.BR
$2.14B -1,129.45%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -877.39%
AU